Powder: -20°C for 3 years
In solvent: -80°C for 2 years
GlyH-101 is a cell-permeable glycinyl hydrazone compound that blocks CFTR with Ki of 1.4 uM.
Description | GlyH-101 is a cell-permeable glycinyl hydrazone compound that blocks CFTR with Ki of 1.4 uM. |
Targets&IC50 | CFTR:4.3 μM(Ki) |
In vitro | GlyH-101 reversibly inhibits CFTR Cl- conductance in <1 min. [1] In rabbit isolated ventricular myocytes, GlyH-101 also blocks cardiac I(Cl.PKA) channels. [2] In transfected FRT (SLC26A9-FRT) cells, GlyH-101 inhibits SLC26A9-mediated Cl- currents. [3] |
In vivo | In mice, Topical GlyH-101 (10 μM) in mice rapidly and reversibly inhibits forskolin-induced hyperpolarization in nasal potential differences. In a cholera model, intraluminal GlyH-101 (2.5 μg) reduces cholera toxin-induced intestinal fluid secretion by approximately 80%.[1] |
Synonyms | GlyH101, GlyH 101 |
Molecular Weight | 493.155 |
Formula | C19H15Br2N3O3 |
CAS No. | 328541-79-3 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 49.3 mg/mL (100 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GlyH-101 328541-79-3 离子通道 自噬 Autophagy CFTR Inhibitor antiproliferative PCT inhibit PS120 cells GlyH101 intestinal fluid GlyH 101 VSORC CFTR-like current Cystic fibrosis transmembrane conductance regulator inhibitor